Frank Bedu-Addo, Ph.D.

Frank Bedu-Addo, Ph.D.

Chief Executive OfficeratPDS Biotechnology· In proxies 2022–2025

Pay in FY2025PDS Biotechnology stock -52.8% the same year

Frank Bedu-Addo, Ph.D. was paid $828.3K in FY2025 (Dec). PDS Biotechnology stock fell 52.8% that year.

Pay$100 in the stock at the end of FY21 → $29
Pay is from the Summary Compensation Table of each PDS Biotechnology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. PDS BiotechnologyPublic company · 4 yr
    • Chief Executive Officer2022 – Present · 4 yrStock in role -82%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?